Surmodics spotlights unique arterial thrombotic study at VIVA25

Traders Union
All News
Market Voices
Surmodics highlights PROWL Registry

Top Stories

Editors' Picks

Stocks

Crypto

Economics

Currencies

Commodities

Market Voices

Companies

Parshwa Turakhiya

04.11.2025

Surmodics spotlights unique arterial thrombotic study at VIVA25 — @Surmodics: Surmodics highlights PROWL Registry

Surmodics has announced its presence at VIVA25, emphasizing the uniqueness of the PROWL Registry study. This research is noteworthy for including all arterial thrombotic clinical presentations as well as Rutherford scores.

The PROWL Registry aims to advance clinical understandings in the cardiovascular field. Attendees at VIVA25 can review the latest findings to deepen their knowledge of vascular complications and treatments through this comprehensive study.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Surmodics’ commitment to advancing vascular intervention, as reflected in the PROWL Registry, builds upon recent innovations such as the Pounce Venous Thrombectomy System for restoring critical vein flow and the introduction of the Pounce LP Thrombectomy System used in limb salvage for peripheral arterial disease patients. Collectively, these developments underscore the company’s expanding influence in both arterial and venous therapeutic domains.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.

Did you like the article?

Editor's Picks for You

By Eugene Komchuk
1 hour ago

Problem with crypto IPOs: How high-profile listings became trap for investors

Editors' Picks

U.S. Bitcoin reserve: Trump’s unrealized crypto promise

By Anastasiia Chabaniuk
Yesterday

U.S. Bitcoin reserve: Trump’s unrealized crypto promise

Editors' Picks

Aiming for leadership: Payment giants prepare a new stablecoin

By Mikhail Vnuchkov
06.07.2026

Aiming for leadership: Payment giants prepare a new stablecoin

Editors' Picks

All Editors' Top Picks

Latest Surmodics News

Transradial approach achieves anterior tibial artery revascularization with Sublime Microcatheter, Surmodics reveals

By Parshwa Turakhiya
14.05.2026

Transradial approach achieves anterior tibial artery revascularization with Sublime Microcatheter, Surmodics reveals

Companies

Surmodics presents new Sublime Microcatheter and Pounce Thrombectomy systems at SIR26TOR

By Mikhail Vnuchkov
15.04.2026

Surmodics presents new Sublime Microcatheter and Pounce Thrombectomy systems at SIR26TOR

Companies

New Surmodics thrombectomy systems unveiled for vascular care at SIR26TOR

By Dmytro Kharkov
10.04.2026

New Surmodics thrombectomy systems unveiled for vascular care at SIR26TOR

Companies

All Surmodics News

Eugene Komchuk
1 hour ago

Problem with crypto IPOs: How high-profile listings became trap for investors

Anastasiia Chabaniuk
Yesterday

U.S. Bitcoin reserve: Trump’s unrealized crypto promise

Mikhail Vnuchkov
06.07.2026

Aiming for leadership: Payment giants prepare a new stablecoin

Pavlo Kot
04.07.2026

Proof of Reserves: the new standard for cryptocurrency exchanges

Eugene Komchuk
03.07.2026

Three trends that could reshape the crypto market over the next decade

Daria Chernytska
6 min ago

Alan Rogers: BTC at $62K as Bitmine acquires 40,000 ETH

Igor Krasulya
11 min ago

Marc Benioff: Salesforce announces $1B investment to expand in Switzerland

Dmytro Kharkov
11 min ago

Peter Spina: Czech central bank increases gold reserves for 40 consecutive months

Parshwa Turakhiya
12 min ago

Gary Black: U.S. stocks fall as Brent crude rises after escalation in Hormuz

Yaroslav Dmytrenko
27 min ago

Crypto trends and strategy to be discussed, Richard Teng notes

Weekly Top Bonuses

Capitalcore

up to $2,500
deposit bonus for all clients

Your capital is at risk.

Top News

Olga Shendetskaya
10 min ago

Trump says Iran ceasefire is effectively finished

Trump says Iran ceasefire is effectively finished

Andrey Mastykin
52 min ago

U.S. stock futures slip as Iran tensions lift oil prices

U.S. stock futures slip as Iran tensions lift oil prices

Igor Krasulya
2 hours ago

Oil prices rise after U.S. launches new Iran strikes

Oil prices rise after U.S. launches new Iran strikes

Ivan Andriyenko
19 hours ago

IEA sees first global gas demand drop since 2022

IEA sees first global gas demand drop since 2022

Parshwa Turakhiya
22 hours ago

Tether brings USDT back to Bitcoin after years away

Tether brings USDT back to Bitcoin after years away

Top 5 companies for you

United States

Live News

Mykhailo Ihnatenko
Now

Rolls-Royce shares face key support after geopolitical selloff

Mykhailo Ihnatenko
Now

Solana price under pressure as Bitcoin weakens

Mykhailo Ihnatenko
Now

Bitcoin price holds above $62,000 as Middle East tensions rise and spot ETF inflows slow.

Anton Kharitonov
Now

Alphabet extends recovery as AI leadership and fusion investment strengthen outlook

Anton Kharitonov
Now

Microsoft extends recovery as AI investments remain in focus

© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186

Risk disclosure:

Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.
Disclaimer:

Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.
Disclosure of advertisers and revenues:

All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.